PureFacts Financial Solutions receives majority investment from GrowthCurve Capital
Goodmans LLP advised PureFacts Financial Solutions in connection with the completion of a majority investment from GrowthCurve Capital.
The investment will propel PureFacts along its growth trajectory by supporting new product development, continued market expansion, and the development and use of leading-edge artificial intelligence (AI) and analytics for the investment industry.
PureFacts is a SaaS provider of end-to-end revenue management solutions for the investment industry.
Featured Work
-
Mergers and Acquisitions
TD Securities Inc. Facilitates Nuvei Corporation’s $6.3 Billion Acquisition by Neon Maple Purchaser Inc.
Goodmans advised TD Securities Inc. in connection to its role as financial advisor and independent valuator for the Special Committee of the Board of Nuvei Corporation (“Nuvei”) in its go-private… -
Mergers and Acquisitions
Converge Technology Solutions Corp. taken private by H.I.G. Capital
Goodmans LLP advised Converge Technology Solutions Corp. in the successful acquisition of all of its issued and outstanding common shares by an affiliate of H.I.G. Capital… -
Technology
PROPELR Growth Fund’s investment in software portfolio company Valsoft Corporation
Goodmans acted for PROPELR Growth Fund in connection with its participation in a US$150 million investment in software portfolio company Valsoft Corporation… -
Competition and Foreign Investment
TRADER Corporation acquired by AutoScout24
Goodmans LLP acted as Canadian regulatory counsel for TRADER Corporation in connection with its acquisition by AutoScout24 (a portfolio company of Hellman & Friedman) from Thoma Bravo… -
Private Equity and Venture Capital
PureFacts Financial Solutions receives majority investment from GrowthCurve Capital
Goodmans LLP advised PureFacts Financial Solutions in connection with the completion of a majority investment from GrowthCurve Capital… -
Mergers and Acquisitions
Apotex acquires Searchlight Pharma Inc.
Goodmans LLP advised Apotex Inc. in connection with its acquisition of Searchlight Pharma Inc…